The Hsp90 Inhibitor 17-DMAG Attenuates Hyperglycemia-Enhanced Hemorrhagic Transformation in Experimental Stroke.
Jiaming ZhangKai WangJia QiXiao-Dong CaoFeng WangPublished in: BioMed research international (2021)
These results implicated that Hsp90 could be a novel therapeutic target in HT following ischemic stroke.